Obesity Flashcards

(44 cards)

1
Q

———- is a leading preventable cause of death worldwide with increasing incidence.

A

Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define obesity

A

Obesity is a medical condition in which excess fat has accumulated to the extent that it may have an adverse effect on health, leading to reduced life expectancy and increased health problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HISTORICAL BACKGROUND
• Oxford dictionary- —————
• Obesity is from the Latin word, ———, which means “——, —— or ——”
• Historically as mankind struggled with food scarcity, obesity was then viewed as a sign of ——— and ————. Still seen as one in many parts of Africa particularly since the ——— epidermic began. Cultural practices like the ——— in Calabar further buttress this.

A

HISTORICAL BACKGROUND
• Oxford dictionary- very fat in a way that is not healthy
• Obesity is from the Latin word, Obesitas, which means “stout, fat or plump”
• Historically as mankind struggled with food scarcity, obesity was then viewed as a sign of wealth and prosperity. Still seen as one in many parts of Africa particularly since the HIV epidermic began. Cultural practices like the fattening room in Calabar further buttress this.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cultural practices like the fattening room in ——— further buttress this.

A

Calabar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The ——- were the first to recognize it as a medical disorder.
•——— wrote that “corpulence is not only a disease itself, but the harbinger of others”

A

The Greeks were the first to recognize it as a medical disorder.
•Hippocrates wrote that “corpulence is not only a disease itself, but the harbinger of others”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

EPIDERMIOLOGY
• In ——, the WHO formally recognised obesity as a global epidemic.
• As of ——, the WHO estimates that at least how many adults are obese with higher rates among ——— than ———.
• Rate also increase with age up to at least — to — yrs

A

EPIDERMIOLOGY
• In 1997, the WHO formally recognised obesity as a global epidemic.
• As of 2008, the WHO estimates that at least 500 million adults are obese with higher rates among women than men.
• Rate also increase with age up to at least 50-60yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

EPIDERMIOLOGY CONT.
• Based on the study by ———— et al, in the year ——, conducted in ——-, among ——— adult residents, it was concluded that overweight and obesity are common in Nigerians, especially among ——— and the ———

A

EPIDERMIOLOGY CONT.
• Based on the study by Adedoyin R.A et al, 2009, conducted in Ile Ife, among 2097 adult residents, it was concluded that overweight and obesity are common in Nigerians, especially among females and the elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CLASSIFICATION
• The ————- is used to classify obesity.

A

• The Body mass index (BMI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CLASSIFICATION
• The Body mass index (BMI) is used to classify obesity.
• Adults are considered obese when their BMI exceeds ——
• For children when the BMI exceeds the —th percentile for age and sex

A

30kg/m2
95th percentile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BMI. CLASSIFICATION
<18.5.
18.5-24.9.
25.0-29.9.
30.0-34.9.
35.0-39.9.
≥40.0.

A

BMI. CLASSIFICATION
<18.5. Underweight
18.5-24.9. Normal weight
25.0-29.9. Overweight
30.0-34.9. Class I Obesity
35.0-39.9. Class II Obesity
≥40.0. Class III Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BMI. CLASSIFICATION
. Underweight
. Normal weight
. Overweight
. Class I Obesity
. Class II Obesity
. Class III Obesity

A

BMI. CLASSIFICATION
<18.5. Underweight
18.5-24.9. Normal weight
25.0-29.9. Overweight
30.0-34.9. Class I Obesity
35.0-39.9. Class II Obesity
≥40.0. Class III Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

WHO MODIFICATION
• BMI —kg/m2 = Severe obesity.
• BMI —kg/m2 + Obesity related health conditions or
• BMI — to —kg/m2 =Morbid obesity.
• BMI — to — = Super obesity.

A

WHO MODIFICATION
• BMI ≥35kg/m2 = Severe obesity.
• BMI ≥35kg/m2 + Obesity related health conditions or
• BMI ≥ 40-44.9kg/m2 =Morbid obesity.
• BMI ≥45 or 50 = Super obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

WHO MODIFICATION
• BMI ≥35kg/m2 = —— obesity.
• BMI ≥35kg/m2 + Obesity related health conditions or
• BMI ≥ 40-44.9kg/m2 =——- obesity.
• BMI ≥45 or 50 = ——- obesity.

A

WHO MODIFICATION
• BMI ≥35kg/m2 = Severe obesity.
• BMI ≥35kg/m2 + Obesity related health conditions or
• BMI ≥ 40-44.9kg/m2 =Morbid obesity.
• BMI ≥45 or 50 = Super obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List possible aetiologies

A

AETIOLOGY
•A combination of excess food energy intake, lack of physical activity, genetics, medical reasons (conditions and drugs) or psychiatric illnesses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

•Light shown on the subject since discovery of Leptin in ——year

A

1994

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Light shown on the subject since discovery of ——— in 1994

A

Leptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PATHOPHYSIOLOGY CONT.
• Several hormonal mechanism participate in the regulation of ——- and ——- intake, storage patterns of ——- tissue and development of —— resistance.
Hormones like ——, ——, ——,——, ——,, —— etc have been studied.

A

PATHOPHYSIOLOGY CONT.
• Several hormonal mechanism participate in the regulation of appetite and food intake, storage patterns of adipose tissue and development of insulin resistance.
Ghrelin, insulin, orexin, PPY 3-36, cholecystokinin, adiponectin etc have been studied.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PATHOPHYSIOLOGY CONT.
• ——— and ——- are considered to be complementary in their influence on appetite.

A

PATHOPHYSIOLOGY CONT.
• Leptin and Ghrelin are considered to be complementary in their influence on appetite.

19
Q

• Ghrelin is produced in the —— in response to ———.
A short term mediator. T or F

A

• Ghrelin is produced in the stomach in response to stomach wall stretch.
F- A short term mediator.

20
Q

PATHOPHYSIOLOGY CONT.
• Leptin is produced by ——— to signal fat storage reserves in the body.
It’s a short term mediator of appetite control (ie to eat more when fat storages are low and less when high) T or F
• Leptin ——— more important than ——-

A

PATHOPHYSIOLOGY CONT.
• Leptin is produced by adipose tissue to signal fat storage reserves in the body.

F -It’s a long term mediator of appetite control

• Leptin resistance more important than deficiency

21
Q

PATHOPHYSIOLOGY CONT.
• Leptin and Ghrelin act on the ———of the hypothalamus
• Several circuits within the hypothalamus integrates appetite. The ———- pathway being the most understood.

A

PATHOPHYSIOLOGY CONT.
arcuate nucleus

The Melanocortin pathway

22
Q

PATHOPHYSIOLOGY CONT.
• Arcuate nucleus has output to the——— hypothalamus and ———hypothalamus
——— – Feeding centre
——— – Satiety centre
• Arcuate nucleus contains how many distinct neurons

A

PATHOPHYSIOLOGY CONT.
• Arcuate nucleus has output to the lateral hypothalamus (LH) and ventromedial hypothalamus (VMH).
LH – Feeding centre
• VMH – Satiety centre
• Arcuate nucleus contains 2 distinct neurons

23
Q

PATHOPHYSIOLOGY CONT.
FIRST ORDER NEURONES include;

A

PATHOPHYSIOLOGY CONT.
FIRST ORDER NEURONES
(1) Neuropeptide Y (NPY) and Agouti-related peptide(AgRP)
(2) Pro-opiomelanocortin (POMC) and amphetamine-regulated transcript (CART

24
Q

PATHOPHYSIOLOGY CONT.
FIRST ORDER NEURONES
(1) Neuropeptide Y (NPY) and Agouti-related peptide(AgRP): Has stimulatory inputs to —— and inhibitory to ——
(2) Pro-opiomelanocortin (POMC) and cocaine and amphetamine-regulated transcript (CART): Has stimulatory inputs to ——— and inhibitory to ——-.

A

PATHOPHYSIOLOGY CONT.
FIRST ORDER NEURONES
(1) Neuropeptide Y (NPY) and Agouti-related peptide(AgRP): Has stimulatory inputs to LH and inhibitory to VMH
(2) Pro-opiomelanocortin (POMC) and cocaine and amphetamine-regulated transcript (CART): Has stimulatory inputs to VMH and inhibitory to LH.

25
PATHOPHYSIOLOGY CONT. • Both groups are regulated in part by ———.
Leptin
26
PATHOPHYSIOLOGY CONT. • Both groups are regulated in part by Leptin. Leptin inhibits the ———group while stimulating the ——— group. • SECOND ORDER NEURONES • The efferent system; second order neurons that control ——— and ——— • Cytokines from the adipose tissue like ——,——,——,——,other chemokines and ——- hormones.
PATHOPHYSIOLOGY CONT. • Both groups are regulated in part by Leptin. Leptin inhibits the Neuropeptide Y/AgoutiRelatedPeptide(NPY/AgRP) group while stimulating the POMC/CART group. (Proopiomelanocortin/ cocaine and amphetamine related transcript.) • SECOND ORDER NEURONES • The efferent system; second order neurons that control food intake and energy expenditure. • Cytokines from the adipose tissue TNF,IL-6,IL-1,IL-18,other chemokines and steroid hormones.
27
PATHOPHYSIOLOGY CONT. • LEPTIN DEFICIENCY; , certain individuals found to have this condition responded to ——— though much success has not been recorded in many others. • Loss of function mutation in the leptin gene; individuals with the ——— state usually exhibit ——— in the first months of life.
PATHOPHYSIOLOGY CONT. • LEPTIN DEFICIENCY; , certain individuals found to have this condition responded to leptin replacement though much success has not been recorded in many others. • Loss of function mutation in the leptin gene; individuals with the homozygous state usually exhibit morbid obesity in the first months of life.
28
Leptin deficiency is not rare T or F
F • very rare
29
PATHOPHYSIOLOGY CONT. • LEPTIN RECEPTOR • Mutation(homozygous); Truncation of the ——- usually abolishes leptin signalling, similar presentation to ———
receptor leptin deficiency
30
PATHOPHYSIOLOGY CONT. • DEFECTS IN THE POMC PATHWAY; • ProOpioMelanocortin is a peptide expressed in the ——-(first order neurons),——-, ——-, ——-. Its also a precursor for the ——,—— and are produced by ———dependent cleavage. • Defects in POMC function cause ——-, ———- and ———-.
PATHOPHYSIOLOGY CONT. • DEFECTS IN THE POMC PATHWAY; • ProOpioMelanocortin is a peptide expressed in the brain(first order neurons),gut, placenta, pancreas. Its also a precursor for the ACTH,MSH and are produced by PC-1 dependent cleavage. • Defects in POMC function cause obesity, altered pigmentation and adrenal insufficiency.
31
PATHOPHYSIOLOGY CONT. • ———mutations also cause obesity with adrenal insufficiency. • ——— receptor mutation(MSH receptor);cause dominant and recessive inherited non syndromic obesity with incomplete penetrance. This causes ——— obesity, its similar to the more common forms .Child usually manifests excessive hunger and food seeking behaviour from — to —months of life with associated increased growth velocity.
PATHOPHYSIOLOGY CONT. • PC-1 mutations also cause obesity with adrenal insufficiency. • MC4R receptor mutation(MSH receptor);cause dominant and recessive inherited non syndromic obesity with incomplete penetrance. This causes childhood obesity, its similar to the more common forms .Child usually manifests excessive hunger and food seeking behaviour from 6-8months of life with associated increased growth velocity.
32
PATHOPHYSIOLOGY CONT. • GUT HORMONES; • GHRELIN; Acts by stimulating the ——— neurons increasing food intake. • Its level in the blood rises before meals and falls between — to —hours postprandially. .
PATHOPHYSIOLOGY CONT. • GUT HORMONES; • GHRELIN; Acts by stimulating the NPY\AgRP(orexigenic neurons) increasing food intake. • Its level in the blood rises before meals and falls between 1-2hours postprandially
33
. There’s marked ———— suppression of ghrelin in obese individuals . This maintains the obesity by enhancing further ghrelin production.
. There’s marked postprandial suppression.
34
PATHOPHYSIOLOGY CONT. • POLYPEPTIDE YY(PYY) : Secreted from the ——— cells of the ileum and colon its found to be low during ——- and increases shortly after ———. • Acts by stimulating the ———-neurons causing a decrease in food intake.
PATHOPHYSIOLOGY CONT. • POLYPEPTIDE YY(PYY) : Secreted from the endocrine cells of the ileum and colon its found to be low during fasting and increases shortly after food intake. • Acts by stimulating the POMC\CART neurons causing a decrease in food intake.
35
PATHOPHYSIOLOGY CONT. • PolypeptideYY levels are found to generally low in individuals with ——- syndrome.
Prader-Willi syndrome. .
36
• AMYLIN; • Peptide secreted with ——- also acts in a similar manner to ———
• AMYLIN; • Peptide secreted with insulin also acts in a similar manner to PolypeptideYY
37
PATHOPHYSIOLOGY CONT. • ADIPONECTIN ,VISFATIN with other complement related acylation stimulating proteins generally have anti-———-, anti-———actions. • In obesity, the proinflammatory /antinflammatory balance is usually tipped towards ——— with increasing obesity and deficient adiponectin levels
PATHOPHYSIOLOGY CONT. • ADIPONECTIN ,VISFATIN with other complement related acylation stimulating proteins generally have anti-inflammatory, anti-atherogenic actions. • In obesity, the proinflammatory /antinflammatory balance is usually tipped towards inflammation with increasing obesity and deficient adiponectin levels
38
PATHOPHYSIOLOGY CONT. • The essence of the storage of fatty acids as ———-in adipocytes is to enhance survival during periods of ————. • Fatty acids are also neatly tucked away as TAGs to prevent their ——— and —— stress.
PATHOPHYSIOLOGY CONT. • The essence of the storage of fatty acids as triacyglycerol (TAGs)in adipocytes is to enhance survival during periods of nutritional deprivation. • Fatty acids are also neatly tucked away as TAGs to prevent their toxicity and oxidant stress.
39
PATHOPHYSIOLOGY CONT. • However the enhanced sympathetic state existent in obese individuals cause ———— of the excess storage of fat. Lipotoxicity ensues from the excess ——— and ———(to the endoplasmic reticulum and mitochondria) with widespread effects in the body organs like ———, ———, ——— etc.
PATHOPHYSIOLOGY CONT. • However the enhanced sympathetic state existent in obese individuals cause lipolysis of the excess storage of fat. Lipotoxicity ensues from the excess free fatty acids(FFAs) and oxidant stress(to the endoplasmic reticulum and mitochondria) with widespread effects in the body organs liver, pancreas, blood vessels etc.
40
PATHOPHYSIOLOGY CONT. • Presence of the FFAs also inhibits ——— and prevent adequate clearance of serum triacylglycerols ;contributing further to the ————.
lipogenesis hypertriglyceridaemia.
41
PATHOPHYSIOLOGY CONT. • ———- lipase also release FFAs from the elevated ———- (containing TAGs) in the serum. • This resulting lipotoxicity result in insulin ———- and insulin ———-.
PATHOPHYSIOLOGY CONT. • Endothelial lipoprotein lipase also release FFAs from the elevated β-lipoproteins (containing TAGs) in the serum. • This resulting lipotoxicity result in insulin receptor dysfunction and insulin resistance.
42
INVESTIGATIONS BASELINE include:
INVESTIGATIONS BASELINE -Biochemical – renal, bone and liver -Full blood count -Fasting plasma glucose -Lipid profile -Serum free thyroxine and TSH -Serum uric acid
43
INVESTIGATIONS FURTHER INVESTIGATIONS depending on clinical picture, include:
FURTHER INVESTIGATIONS depending on clinical picture -24hr urine free cortisol -ECG and chest X- ray -Respiratory function tests -plasma leptin- not routinely indicated
44
TREATMENT The main treatment for obesity consists of ——— and ———. Drug therapy: -orlistat (inhibits pancreatic and gastric lipases) -Lorcaserin (5’HT agonist) -Phentermine and topiramate -———analogues, ——- inhibitors are also being subjected to further research studies. Surgery: ——— surgery and ———-. • —% may have complications • —% may require reoperation.
TREATMENT The main treatment for obesity consists of dieting and physical exercise. Drug therapy: -orlistat (inhibits pancreatic and gastric lipases) -Lorcaserin (5’HT agonist) -Phentermine and topiramate -leptin analogues, NPY inhibitors are also being subjected to further research studies. Surgery: Bariatric surgery and liposuction. • 17% may have complications • 7% may require reoperation.